Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clavel

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumorsG Catimel, G G Chabot, J P Guastalla, et al.
Presse Medicale (Paris, France : 1983)|April 7, 1990
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy]V Trillet, F Chauvin, F Champel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials GroupW W ten Bokkel Huinink, A M Prove, M Piccart, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) studyE E Holdener, M Clavel, C Sessa, et al.
Investigational New Drugs|January 1, 1990
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanomaS B Kaye, M Clavel, P Dodion, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimationM C Launay-Iliadis, R Bruno, V Cosson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative GroupM Clavel, J B Vermorken, F Cognetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative GroupJ H Schornagel, J Verweij, P H de Mulder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group studyJ H Schornagel, J Verweij, P H de Mulder, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumorsG Catimel, G G Chabot, J P Guastalla, et al.
Presse Medicale (Paris, France : 1983)|April 7, 1990
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy]V Trillet, F Chauvin, F Champel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials GroupW W ten Bokkel Huinink, A M Prove, M Piccart, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) studyE E Holdener, M Clavel, C Sessa, et al.
Investigational New Drugs|January 1, 1990
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanomaS B Kaye, M Clavel, P Dodion, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimationM C Launay-Iliadis, R Bruno, V Cosson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative GroupM Clavel, J B Vermorken, F Cognetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative GroupJ H Schornagel, J Verweij, P H de Mulder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group studyJ H Schornagel, J Verweij, P H de Mulder, et al.
Pageof 16